A CALCIUM CARBONATE, FAMOTIDINE; MAGNESIUM HYDROXIDE CEP of the European Pharmacopoeia monograph is often referred to as a CALCIUM CARBONATE, FAMOTIDINE; MAGNESIUM HYDROXIDE Certificate of Suitability (COS). The purpose of a CALCIUM CARBONATE, FAMOTIDINE; MAGNESIUM HYDROXIDE CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of CALCIUM CARBONATE, FAMOTIDINE; MAGNESIUM HYDROXIDE EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of CALCIUM CARBONATE, FAMOTIDINE; MAGNESIUM HYDROXIDE to their clients by showing that a CALCIUM CARBONATE, FAMOTIDINE; MAGNESIUM HYDROXIDE CEP has been issued for it. The manufacturer submits a CALCIUM CARBONATE, FAMOTIDINE; MAGNESIUM HYDROXIDE CEP (COS) as part of the market authorization procedure, and it takes on the role of a CALCIUM CARBONATE, FAMOTIDINE; MAGNESIUM HYDROXIDE CEP holder for the record. Additionally, the data presented in the CALCIUM CARBONATE, FAMOTIDINE; MAGNESIUM HYDROXIDE CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the CALCIUM CARBONATE, FAMOTIDINE; MAGNESIUM HYDROXIDE DMF.
A CALCIUM CARBONATE, FAMOTIDINE; MAGNESIUM HYDROXIDE CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. CALCIUM CARBONATE, FAMOTIDINE; MAGNESIUM HYDROXIDE CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of CALCIUM CARBONATE, FAMOTIDINE; MAGNESIUM HYDROXIDE suppliers with CEP (COS) on PharmaCompass.